InsiderClue
← All stocks

Scribe Therapeutics, Inc.

SCTX Net buying
CIK 0001853921 #3010 in the set updated 17 Sep 2026
Bought (12 mo)
$71.34M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$71.34M
+$71.34M against sales at will

By person

7 insiders · 9 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Aghazadeh Behzad
Director
$36.26M (3)
—
+$36.26M
3,088,888
$56.37M
+342.8%
GORDON CARL L
Director
$15.00M (1)
—
+$15.00M
1,348,825
$24.62M
—
ORBIMED ADVISORS LLC entity
Director
$15.00M (1)
—
+$15.00M
1,348,825
$24.62M
—
AH Bio Fund II, L.P. entity
10% owner
$5.00M (1)
—
+$5.00M
2,385,075
$43.53M
—
Lucas Svetlana
Chief Business Officer
$45.00K (1)
—
+$45.00K
3,000
$54.75K
—
Parrot David
Chief Financial Officer
$39.99K (2)
—
+$39.99K
1,333
$24.33K
—
Doudna Jennifer A
10% owner
—
—
—
603,547
$11.01M
+2.1%

No percentages here. Scribe Therapeutics, Inc. reports its share count only per share class, which the XBRL frames API does not carry.

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Aghazadeh Behzad
28 Jul 2026
Director
Buy indirect
7,905
$18.25
$144.27K
ORBIMED ADVISORS LLC
27 Jul 2026
Director
Buy indirect
1,000,000
$15.00
$15.00M
GORDON CARL L
27 Jul 2026
Director
Buy indirect
1,000,000
$15.00
$15.00M
AH Bio Fund II, L.P.
27 Jul 2026
10% owner
Buy indirect
333,333
$15.00
$5.00M
Aghazadeh Behzad
24 Jul 2026
Director
Buy indirect
50,000
$22.31
$1.12M
Aghazadeh Behzad
24 Jul 2026
Director
Buy indirect
2,333,333
$15.00
$35.00M
Parrot David
23 Jul 2026
Chief Financial Officer
Buy indirect
1,333
$15.00
$20.00K
Parrot David
23 Jul 2026
Chief Financial Officer
Buy indirect
1,333
$15.00
$20.00K
Lucas Svetlana
23 Jul 2026
Chief Business Officer
Buy indirect
3,000
$15.00
$45.00K

What was left out

Form 4 filings counted 13
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 3,459,553
History held since 27 Jul 2026